Close

Immunogen, Inc. (IMGN) Tops Q3 EPS by 1c

April 27, 2012 7:20 AM EDT
Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.24), $0.01 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.25 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings